Novo Nordisk Partners With Anthropic to Boost AI Drug Research

Danish drug giant Novo Nordisk is partnering with American technology firm Anthropic.

Anthropic created the popular artificial intelligence language model Claude.

Novo Nordisk announced the new partnership in a recent press release.

The collaboration aims to accelerate medical research and development.

Novo Nordisk will first test Claude Science in specific research workflows.

Chief Executive Mike Doustdar shared the company's vision for this project.

He stated that Novo wants to be the world's most AI-driven health company.

This deal builds on existing partnerships with other technology firms.

Anthropic co-founder Dario Amodei also commented on the potential of artificial intelligence.

He said AI could condense a century of medical breakthroughs into ten years.

Anthropic recently faced public attention after a researcher resigned.

The researcher left the company while warning about artificial intelligence risks.

Danish broadcaster DR reported these details from the official announcement.